New insights into invasive aspergillosis - from the pathogen to the disease

Current Pharmaceutical Design

Volumn 19, Issue 20, 2013, Pages 3679-3688

  Binder, Ulrike ^a   Lass Flörl, Cornelia ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

Classification of IA; Innate immune response; Invasive aspergillosis; Pathogenicity factors; Virulence

Indexed keywords

AMPHOTERICIN B; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 4; IRON; PATTERN RECOGNITION RECEPTOR; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 9; VORICONAZOLE;

ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS; ANTIMICROBIAL THERAPY; ASPERGILLOMA; ASPERGILLUS FUMIGATUS; ASTHMA; CYTOKINE PRODUCTION; HEAT TOLERANCE; HUMAN; IMMUNOCOMPROMISED PATIENT; INNATE IMMUNITY; INVASIVE ASPERGILLOSIS; LUNG ASPERGILLOSIS; MORTALITY; NONHUMAN; PRIORITY JOURNAL; REVIEW;

ANIMALS; ANTIFUNGAL AGENTS; ASPERGILLOSIS; ASPERGILLUS FUMIGATUS; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNITY, INNATE; IMMUNOCOMPROMISED HOST; SEVERITY OF ILLNESS INDEX; VIRULENCE FACTORS;

EID: 84878665827     PISSN: 13816128     EISSN: 18734286     Source Type: Journal    
DOI: 10.2174/13816128113199990366     Document Type: Review

References (93)

1. Dagenais TR, Keller NP. Pathogenesis of Aspergillus fumigatus in Invasive Aspergillosis. Clin Microbiol Rev 2009; 22: 447-65.
2. Denning DW. Invasive aspergillosis. Clin Infect Dis 1998; 26: 781-803; quiz 804-5.
3. Goodley JM, Clayton YM, Hay RJ. Environmental sampling for aspergilli during building construction on a hospital site. J Hosp Infect 1994; 26: 27-35.
4. Latge JP. Aspergillus fumigatus and aspergillosis. Clin Microbiol Rev 1999; 12: 310-50.
5. Balloy V, Chignard M. The innate immune response to Aspergillus fumigatus. Microbes Infect 2009; 11: 919-27.
6. Casadevall A, Pirofski LA. Host-pathogen interactions: redefining the basic concepts of virulence and pathogenicity. Infect Immun 1999; 67: 3703-13.
7. Casadevall A, Pirofski LA. The damage-response framework of microbial pathogenesis. Nat Rev Microbiol 2003; 1: 17-24.
8. Park SJ, Mehrad B. Innate immunity to Aspergillus species. Clin Microbiol Rev 2009; 22: 535-51.
9. Walsh TJ, Dixon DM. Spectrum of Mycoses. 1996.
10. Bodey GP, Vartivarian S. Aspergillosis. Eur J Clin Microbiol Infect Dis 1989; 8: 413-37.
11. Greenberger PA. Chapter 18: Allergic bronchopulmonary aspergillosis. Allergy Asthma Proc 2012; 33 Suppl 1: 61-3.
12. Hogan C, Denning DW. Allergic bronchopulmonary aspergillosis and related allergic syndromes. Semin Respir Crit Care Med 2011; 32: 682-92.
13. Knutsen AP, Bush RK, Demain JG, et al. Fungi and allergic lower respiratory tract diseases. J Allergy Clin Immunol 2012; 129: 280-91; quiz 292-3.
14. Tripathi SK, Srivastava R, Tg R, Anand S. Allergic bronchopulmonary aspergillosis: still a mirage or ignorance. BMJ Case Rep 2012; 2012.
15. Denning DW, Follansbee SE, Scolaro M, Norris S, Edelstein H, Stevens DA. Pulmonary aspergillosis in the acquired immunodeficiency syndrome. N Engl J Med 1991; 324: 654-62.
16. Kemper CA, Hostetler JS, Follansbee SE, et al. Ulcerative and plaque-like tracheobronchitis due to infection with Aspergillus in patients with AIDS. Clin Infect Dis 1993; 17: 344-52.
17. Nash G, Irvine R, Kerschmann RL, Herndier B. Pulmonary aspergillosis in acquired immune deficiency syndrome: autopsy study of an emerging pulmonary complication of human immunodeficiency virus infection. Hum Pathol 1997; 28: 1268-75.
18. Viollier AF, Peterson DE, De Jongh CA, et al. Aspergillus sinusitis in cancer patients. Cancer 1986; 58: 366-71.
19. Wingard JR, Beals SU, Santos GW, Merz WG, Saral R. Aspergillus infections in bone marrow transplant recipients. Bone Marrow Transplant 1987; 2: 175-81.
20. Abad A, Fernandez-Molina JV, Bikandi J, et al. What makes Aspergillus fumigatus a successful pathogen? Genes and molecules involved in invasive aspergillosis. Rev Iberoam Micol 2010; 27: 155-82.
21. Osherov N. The virulence of Aspergillus fumigatus. In: ed. eds., New insights in medical mycology 2007.
22. Beffa T, Staib F, Lott Fischer J, et al. Mycological control and surveillance of biological waste and compost. Med Mycol 1998; 36 Suppl 1: 137-45.
23. Ryckeboer J, Mergaert J, Coosemans J, Deprins K, Swings J. Microbiological aspects of biowaste during composting in a monitored compost bin. J Appl Microbiol 2003; 94: 127-37.
24. Zhou H, Hu H, Zhang L, Li R, Ouyang H, Ming J, Jin C. OMannosyltransferase 1 in Aspergillus fumigatus (AfPmt1p) is crucial for cell wall integrity and conidium morphology, especially at an elevated temperature. Eukaryot Cell 2007; 6: 2260-8.
25. Bhabhra R, Miley MD, Mylonakis E, et al. Disruption of the Aspergillus fumigatus gene encoding nucleolar protein CgrA impairs thermotolerant growth and reduces virulence. Infect Immun 2004; 72: 4731-40.
26. Wagener J, Echtenacher B, Rohde M, et al. The putative alpha-1,2-mannosyltransferase AfMnt1 of the opportunistic fungal pathogen Aspergillus fumigatus is required for cell wall stability and full virulence. Eukaryot Cell 2008; 7: 1661-73.
27. Do JH, Yamaguchi R, Miyano S. Exploring temporal transcription regulation structure of Aspergillus fumigatus in heat shock by state space model. BMC Genomics 2009; 10: 306.
28. Albrecht D, Guthke R, Brakhage AA, Kniemeyer O. Integrative analysis of the heat shock response in Aspergillus fumigatus. BMC Genomics 2010; 11: 32.
29. Palmer GE, Askew DS, Williamson PR. The diverse roles of autophagy in medically important fungi. Autophagy 2008; 4: 982-8.
30. Kothary MH, Chase T, Jr., Macmillan JD. Correlation of elastase production by some strains of Aspergillus fumigatus with ability to cause pulmonary invasive aspergillosis in mice. Infect Immun 1984; 43: 320-5.
31. Alp S, Arikan S. Investigation of extracellular elastase, acid proteinase and phospholipase activities as putative virulence factors in clinical isolates of Aspergillus species. J Basic Microbiol 2008; 48: 331-7.
32. Vickers I, Reeves EP, Kavanagh KA, Doyle S. Isolation, activity and immunological characterisation of a secreted aspartic protease, CtsD, from Aspergillus fumigatus. Protein Expr Purif 2007; 53: 216-24.
33. Rementeria A, Lopez-Molina N, Ludwig A, et al. Genes and molecules involved in Aspergillus fumigatus virulence. Rev Iberoam Micol 2005; 22: 1-23.
34. Kogan TV, Jadoun J, Mittelman L, Hirschberg K, Osherov N. Involvement of secreted Aspergillus fumigatus proteases in disruption of the actin fiber cytoskeleton and loss of focal adhesion sites in infected A549 lung pneumocytes. J Infect Dis 2004; 189: 1965-73.
35. Sasse C, Bignell EM, Hasenberg M, et al. Basal expression of the Aspergillus fumigatus transcriptional activator CpcA is sufficient to support pulmonary aspergillosis. Fungal Genet Biol 2008; 45: 693-704.
36. Ibrahim-Granet O, Dubourdeau M, Latge JP, et al. Methylcitrate synthase from Aspergillus fumigatus is essential for manifestation of invasive aspergillosis. Cell Microbiol 2008; 10: 134-48.
37. Richie DL, Feng X, Krishnan K, Askew DS. Secretion stress and antifungal resistance: an Achilles' heel of Aspergillus fumigatus? Med Mycol 2011; 49 Suppl 1: S101-6.
38. Richie DL, Hartl L, Aimanianda V, et al. A role for the unfolded protein response (UPR) in virulence and antifungal susceptibility in Aspergillus fumigatus. PLoS Pathog 2009; 5: e1000258.
39. Feng X, Krishnan K, Richie DL, et al. HacA-independent functions of the ER stress sensor IreA synergize with the canonical UPR to influence virulence traits in Aspergillus fumigatus. PLoS Pathog 2011; 7: e1002330.
40. Richie DL, Feng X, Hartl L, et al. The virulence of the opportunistic fungal pathogen Aspergillus fumigatus requires cooperation between the endoplasmic reticulum-associated degradation pathway (ERAD) and the unfolded protein response (UPR). Virulence 2011; 2: 12-21.
41. Kaplan CD, Kaplan J. Iron acquisition and transcriptional regulation. Chem Rev 2009; 109: 4536-52.
42. Schrettl M, Bignell E, Kragl C, et al. Siderophore biosynthesis but not reductive iron assimilation is essential for Aspergillus fumigatus virulence. J Exp Med 2004; 200: 1213-9.
43. Haas H. Iron-A Key Nexus in the Virulence of Aspergillus fumigatus. Front Microbiol 2012; 3: 28.
44. Cramer RA, Rivera A, Hohl TM. Immune responses against Aspergillus fumigatus: what have we learned? Curr Opin Infect Dis 2011; 24: 315-22.
45. Ernst JF, Tielker D. Responses to hypoxia in fungal pathogens. Cell Microbiol 2009; 11: 183-90.
46. Willger SD, Puttikamonkul S, Kim KH, et al. A sterol-regulatory element binding protein is required for cell polarity, hypoxia adaptation, azole drug resistance, and virulence in Aspergillus fumigatus. PLoS Pathog 2008; 4: e1000200.
47. Hughes AL, Todd BL, Espenshade PJ. SREBP pathway responds to sterols and functions as an oxygen sensor in fission yeast. Cell 2005; 120: 831-42.
48. Alangaden GJ. Nosocomial fungal infections: epidemiology, infection control, and prevention. Infect Dis Clin North Am 2011; 25: 201-25.
49. Mahfouz T, Anaissie E. Prevention of fungal infections in the immunocompromised host. Curr Opin Investig Drugs 2003; 4: 974-90.
50. Marr KA, Patterson T, Denning D. Aspergillosis. Pathogenesis, clinical manifestations, and therapy. Infect Dis Clin North Am 2002; 16: 875-94, vi.
51. Singh N, Paterson DL. Aspergillus infections in transplant recipients. Clin Microbiol Rev 2005; 18: 44-69.
52. Upton A, Kirby KA, Carpenter P, Boeckh M, Marr KA. Invasive aspergillosis following hematopoietic cell transplantation: outcomes and prognostic factors associated with mortality. Clin Infect Dis 2007; 44: 531-40.
53. Pagano L, Caira M, Picardi M, et al. Invasive Aspergillosis in patients with acute leukemia: update on morbidity and mortality--SEIFEM-C Report. Clin Infect Dis 2007; 44: 1524-5.
54. Marr KA, Carter RA, Boeckh M, Martin P, Corey L. Invasive aspergillosis in allogeneic stem cell transplant recipients: changes in epidemiology and risk factors. Blood 2002; 100: 4358-66.
55. Baddley JW. Clinical risk factors for invasive aspergillosis. Med Mycol 2011; 49 Suppl 1: S7-S12.
56. Morgan J, Wannemuehler KA, Marr KA, et al. Incidence of invasive aspergillosis following hematopoietic stem cell and solid organ transplantation: interim results of a prospective multicenter surveillance program. Med Mycol 2005; 43 Suppl 1: S49-58.
57. Segal BH. Aspergillosis. N Engl J Med 2009; 360: 1870-84.
58. Husain S, Tollemar J, Dominguez EA, et al. Changes in the spectrum and risk factors for invasive candidiasis in liver transplant recipients: prospective, multicenter, case-controlled study. Transplantation 2003; 75: 2023-9.
59. Singh N, Husain S. Invasive aspergillosis in solid organ transplant recipients. Am J Transplant 2009; 9 Suppl 4: S180-91.
60. Holding KJ, Dworkin MS, Wan PC, et al. Aspergillosis among people infected with human immunodeficiency virus: incidence and survival. Adult and Adolescent Spectrum of HIV Disease Project. Clin Infect Dis 2000; 31: 1253-7.
61. Wallace JM, Lim R, Browdy BL, et al. Risk factors and outcomes associated with identification of Aspergillus in respiratory specimens from persons with HIV disease. Pulmonary Complications of HIV Infection Study Group. Chest 1998; 114: 131-7.
62. Meersseman W, Lagrou K, Maertens J, et al. Galactomannan in bronchoalveolar lavage fluid: a tool for diagnosing aspergillosis in intensive care unit patients. Am J Respir Crit Care Med 2008; 177: 27-34.
63. Meersseman W, Van Wijngaerden E. Invasive aspergillosis in the ICU: an emerging disease. Intensive Care Med 2007; 33: 1679-81.
64. Meersseman W, Vandecasteele SJ, Wilmer A, Verbeken E, Peetermans WE, Van Wijngaerden E. Invasive aspergillosis in critically ill patients without malignancy. Am J Respir Crit Care Med 2004; 170: 621-5.
65. Garnacho-Montero J, Amaya-Villar R, Ortiz-Leyba C, et al. Isolation of Aspergillus spp. from the respiratory tract in critically ill patients: risk factors, clinical presentation and outcome. Crit Care 2005; 9: R191-9.
66. Trof RJ, Beishuizen A, Debets-Ossenkopp YJ, Girbes AR, Groeneveld AB. Management of invasive pulmonary aspergillosis in non-neutropenic critically ill patients. Intensive Care Med 2007; 33: 1694-703.
67. Monneret G, Venet F, Kullberg BJ, Netea MG. ICU-acquired immunosuppression and the risk for secondary fungal infections. Med Mycol 2011; 49 Suppl 1: S17-23.
68. Hope WW, Walsh TJ, Denning DW. Laboratory diagnosis of invasive aspergillosis. Lancet Infect Dis 2005; 5: 609-22.
69. McCormack FX, Whitsett JA. The pulmonary collectins, SP-A and SP-D, orchestrate innate immunity in the lung. J Clin Invest 2002; 109: 707-12.
70. Palaniyar N, Zhang L, Kuzmenko A, et al. The role of pulmonary collectin N-terminal domains in surfactant structure, function, and homeostasis in vivo. J Biol Chem 2002; 277: 26971-9.
71. Wright JR. Immunoregulatory functions of surfactant proteins. Nat Rev Immunol 2005; 5: 58-68.
72. Madan T, Reid KB, Singh M, Sarma PU, Kishore U. Susceptibility of mice genetically deficient in the surfactant protein (SP)-A or SPD gene to pulmonary hypersensitivity induced by antigens and allergens of Aspergillus fumigatus. J Immunol 2005; 174: 6943-54.
73. Dumestre-Perard C, Lamy B, Aldebert D, et al. Aspergillus conidia activate the complement by the mannan-binding lectin C2 bypass mechanism. J Immunol 2008; 181: 7100-5.
74. Jahn B, Langfelder K, Schneider U, Schindel C, Brakhage AA. PKSP-dependent reduction of phagolysosome fusion and intracellular kill of Aspergillus fumigatus conidia by human monocyte-derived macrophages. Cell Microbiol 2002; 4: 793-803.
75. Levitz SM, Diamond RD. Mechanisms of resistance of Aspergillus fumigatus Conidia to killing by neutrophils in vitro. J Infect Dis 1985; 152: 33-42.
76. Levitz SM, Farrell TP. Human neutrophil degranulation stimulated by Aspergillus fumigatus. J Leukoc Biol 1990; 47: 170-5.
77. Bruns S, Kniemeyer O, Hasenberg M, et al. Production of extracellular traps against Aspergillus fumigatus in vitro and in infected lung tissue is dependent on invading neutrophils and influenced by hydrophobin RodA. PLoS Pathog 2010; 6: e1000873.
78. McCormick A, Heesemann L, Wagener J, et al. NETs formed by human neutrophils inhibit growth of the pathogenic mold Aspergillus fumigatus. Microbes Infect 2010; 12: 928-36.
79. Zarember KA, Sugui JA, Chang YC, Kwon-Chung KJ, Gallin JI. Human polymorphonuclear leukocytes inhibit Aspergillus fumigatus conidial growth by lactoferrin-mediated iron depletion. J Immunol 2007; 178: 6367-73.
80. Bonnett CR, Cornish EJ, Harmsen AG, Burritt JB. Early neutrophil recruitment and aggregation in the murine lung inhibit germination of Aspergillus fumigatus Conidia. Infect Immun 2006; 74: 6528-39.
81. Svirshchevskaya EV, Shevchenko MA, Huet D, et al. Susceptibility of mice to invasive aspergillosis correlates with delayed cell influx into the lungs. Int J Immunogenet 2009; 36: 289-99.
82. Cortez KJ, Lyman CA, Kottilil S, et al. Functional genomics of innate host defense molecules in normal human monocytes in response to Aspergillus fumigatus. Infect Immun 2006; 74: 2353-65.
83. Rodland EK, Mattingsdal M, Olstad OK, et al. Expression of genes in normal human monocytes in response to Aspergillus fumigatus. Med Mycol 2008; 46: 327-36.
84. Roilides E, Sein T, Holmes A, et al. Effects of macrophage colonystimulating factor on antifungal activity of mononuclear phagocytes against Aspergillus fumigatus. J Infect Dis 1995; 172: 1028-34.
85. Roilides E, Holmes A, Blake C, Venzon D, Pizzo PA, Walsh TJ. Antifungal activity of elutriated human monocytes against Aspergillus fumigatus hyphae: enhancement by granulocytemacrophage colony-stimulating factor and interferon-gamma. J Infect Dis 1994; 170: 894-9.
86. Perkhofer S, Kehrel BE, Dierich MP, et al. Human platelets attenuate Aspergillus species via granule-dependent mechanisms. J Infect Dis 2008; 198: 1243-6.
87. Basse PH, Hokland P, Gundersen HJ, Hokland M. Enumeration of organ-associated natural killer cells in mice: application of a new stereological method. APMIS 1992; 100: 202-8.
88. Schmidt S, Tramsen L, Hanisch M, et al. Human natural killer cells exhibit direct activity against Aspergillus fumigatus hyphae, but not against resting conidia. J Infect Dis 2011; 203: 430-5.
89. Serrano-Gomez D, Dominguez-Soto A, Ancochea J, Jimenez-Heffernan JA, Leal JA, Corbi AL. Dendritic cell-specific intercellular adhesion molecule 3-grabbing nonintegrin mediates binding and internalization of Aspergillus fumigatus conidia by dendritic cells and macrophages. J Immunol 2004; 173: 5635-43.
90. Serrano-Gomez D, Leal JA, Corbi AL. DC-SIGN mediates the binding of Aspergillus fumigatus and keratinophylic fungi by human dendritic cells. Immunobiology 2005; 210: 175-83.
91. Bozza S, Gaziano R, Spreca A, et al. Dendritic cells transport conidia and hyphae of Aspergillus fumigatus from the airways to the draining lymph nodes and initiate disparate Th responses to the fungus. J Immunol 2002; 168: 1362-71.
92. Stuehler C, Khanna N, Bozza S, et al. Cross-protective TH1 immunity against Aspergillus fumigatus and Candida albicans. Blood 2011; 117: 5881-91.
93. Carvalho A, Cunha C, Bistoni F, Romani L. Immunotherapy of aspergillosis. Clin Microbiol Infect 2012; 18: 120-5.